Facilitate your cancer research with highly-characterized cancer antibodies from Rockland. Our antibodies have been highly-validated to recognize relevant cancer targets for studying metastasis, apoptosis, autophagy, metabolism, and more. Many of our antibodies have been developed in partnership with renowned institutions, such as the MD Anderson Cancer Center, The Wistar Institute, National Cancer Institute, and Emory University, to combine basic and applied research principles for the development of better biomedical research reagents. Choose Rockland’s cancer antibodies for reproducible results that support innovative research and lead to significant advances in the fight against cancer.
_antibody_1_IHC_4x3.jpg)
